R J Winter1, J T Young2, M Stoové3, P A Agius4, M E Hellard3, S A Kinner5. 1. Centre for Population Health, Burnet Institute, Melbourne, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Victoria, Australia. Electronic address: rwinter@burnet.edu.au. 2. Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia; Centre for Health Services Research, School of Population Health, The University of Western Australia, Western Australia, Australia; National Drug Research Institute, Curtin University, Perth, Western Australia, Australia. 3. Centre for Population Health, Burnet Institute, Melbourne, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Victoria, Australia. 4. Centre for Population Health, Burnet Institute, Melbourne, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Victoria, Australia; Judith Lumley Centre, La Trobe University, Melbourne, Victoria, Australia. 5. School of Public Health and Preventive Medicine, Monash University, Victoria, Australia; Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia; Griffith Criminology Institute & Menzies Health Institute Queensland, Griffith University, Queensland, Australia; Mater Research Institute, University of Queensland, Queensland, Australia; Centre for Adolescent Health, Murdoch Childrens Research Institute, Victoria, Australia.
Abstract
INTRODUCTION: Ex-prisoners with a history of injecting drug use (IDU) experience disproportionate drug-related harm. Rapid resumption of substance use following prison release is common and evidenced in high rates of overdose mortality. However, few studies have documented the rate of IDU resumption following prison release or identified risk factors for relapse. METHODS: Structured interviews were conducted with 533 adults with a history of IDU in Queensland, Australia prior to release from prison and approximately 1, 3 and 6 months post-release. Incidence of self-reported IDU resumption was calculated overall and for each follow-up interval. Risk factors associated with time to resumption of IDU were estimated using discrete-time survival analysis. RESULTS: IDU resumption was reported by 41% of participants during a median of 98days of follow-up (IQR=94-121), an overall crude incidence of 1.06 per person-year. The highest rate was observed in the first month (23%; crude incidence 2.24 per person-year). In adjusted discrete-time survival analyses, being unemployed at the previous interview (AHR=1.59; 95%CI:1.10-2.30), shorter incarceration (≤90days vs. >365days; AHR=2.20; 95%CI:1.33-3.65), and IDU during the index incarceration (AHR=2.80; 95%CI:1.92-4.09) were significantly associated with time to IDU resumption; parole was protective (AHR=0.66; 95%CI:0.47-0.92). CONCLUSIONS: Evidence-based efforts to prevent IDU in prison and IDU resumption after release are important for both prisoner and public health. Enhancing opportunities for employment and capitalising on the short-term benefits of parole for ex-prisoners may delay resumption of IDU after release from prison. These strategies should complement rather than replace harm reduction efforts for this high-risk population.
INTRODUCTION: Ex-prisoners with a history of injecting drug use (IDU) experience disproportionate drug-related harm. Rapid resumption of substance use following prison release is common and evidenced in high rates of overdose mortality. However, few studies have documented the rate of IDU resumption following prison release or identified risk factors for relapse. METHODS: Structured interviews were conducted with 533 adults with a history of IDU in Queensland, Australia prior to release from prison and approximately 1, 3 and 6 months post-release. Incidence of self-reported IDU resumption was calculated overall and for each follow-up interval. Risk factors associated with time to resumption of IDU were estimated using discrete-time survival analysis. RESULTS: IDU resumption was reported by 41% of participants during a median of 98days of follow-up (IQR=94-121), an overall crude incidence of 1.06 per person-year. The highest rate was observed in the first month (23%; crude incidence 2.24 per person-year). In adjusted discrete-time survival analyses, being unemployed at the previous interview (AHR=1.59; 95%CI:1.10-2.30), shorter incarceration (≤90days vs. >365days; AHR=2.20; 95%CI:1.33-3.65), and IDU during the index incarceration (AHR=2.80; 95%CI:1.92-4.09) were significantly associated with time to IDU resumption; parole was protective (AHR=0.66; 95%CI:0.47-0.92). CONCLUSIONS: Evidence-based efforts to prevent IDU in prison and IDU resumption after release are important for both prisoner and public health. Enhancing opportunities for employment and capitalising on the short-term benefits of parole for ex-prisoners may delay resumption of IDU after release from prison. These strategies should complement rather than replace harm reduction efforts for this high-risk population.
Authors: Alexander R Bazazi; Jeffrey A Wickersham; Martin P Wegman; Gabriel J Culbert; Veena Pillai; Roman Shrestha; Haider Al-Darraji; Michael M Copenhaver; Adeeba Kamarulzaman; Frederick L Altice Journal: Contemp Clin Trials Date: 2017-05-04 Impact factor: 2.226
Authors: Shabbar I Ranapurwala; Meghan E Shanahan; Apostolos A Alexandridis; Scott K Proescholdbell; Rebecca B Naumann; Daniel Edwards; Stephen W Marshall Journal: Am J Public Health Date: 2018-07-19 Impact factor: 9.308
Authors: Divya K Chandra; Alexander R Bazazi; Muzammil A Nahaboo Solim; Adeeba Kamarulzaman; Frederick L Altice; Gabriel J Culbert Journal: HIV Res Clin Pract Date: 2019-05-01
Authors: Amy Kirwan; Michael Curtis; Paul Dietze; Campbell Aitken; Emma Woods; Shelley Walker; Stuart Kinner; James Ogloff; Tony Butler; Mark Stoové Journal: J Urban Health Date: 2019-06 Impact factor: 3.671
Authors: Anne Bukten; Ingunn Olea Lund; Stuart A Kinner; Eline Borger Rognli; Ingrid Amalia Havnes; Ashley Elizabeth Muller; Marianne Riksheim Stavseth Journal: Health Justice Date: 2020-05-12